Osiris Therapeutics, Inc. (OSIR) Announces Therésa K. Dixon As General Manager Of Market Access And Reimbursement
3/26/2014 7:20:17 AM
Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading stem cell company focused on developing and marketing products to treat conditions in wound care, orthopedic and sports medicine markets, is pleased to announce the appointment of Therésa K. Dixon, to General Manager, Market Access and Reimbursement, reporting to Lode Debrabandere, Ph.D., President and Chief Executive Officer.
Help employers find you! Check out all the jobs and post your resume.
comments powered by